Asia-Pacific Stool Diagnostic Market - Industry Trends and Forecast to 2030

Description

List of Tables

The Asia-Pacific stool diagnostic market is projected to register a CAGR of 7.1% from 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation:

Asia-Pacific Stool Diagnostic Market, By Test Type (Fecal Occult Blood Test, Fecal Biomarker Test, Pathogen Tests, Stool Antigen Test, Fecal Elastase Test, Microscopy Test, and Other Tests), Product Type (Instruments and Reagents), Mode (Laboratories Based Testing and Point of Care Testing), Application (Irritable Bowel Syndrome, Ulcerative Colitis, Crohn's Disease, Cancer, Diarrhea, Hemorrhoids, and Others), End User (Hospitals, Diagnostic Centers, Laboratory, Specialty Clinics, Academic Institutions and Research Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, Online Sales, and Others), Country (Japan, China, South Korea, India, Singapore, Thailand, Indonesia, Malaysia, Philippines, Australia, New Zealand, Vietnam, Taiwan, Brunei, Nepal, Bangladesh, Sri Lanka, Pakistan, Hong Kong, Maldives, Mongolia, Cambodia, Laos, and Rest of Asia-Pacific) Industry Trends and Forecast to 2030.

Some of the major factors contributing to the growth of the Asia-Pacific stool diagnostic market are:

Increasing prevalence of the gastrointestinal disorder

Increase in demand for point-of-care stool diagnostic devices

Market Players

Some major companies dealing in the Asia-Pacific stool diagnostic market are:

Abbott

Meridian Bioscience Inc.

BIOMERIEUX

Beckman Coulter, Inc. (Subsidiary of Danaher)

DiaSorin S.p.A.

Runmei

Molbio Diagnostics Pvt. Ltd.

Quidel Corporation

Prenetics Limited

Sekisui Diagnostics (A Part of SEKISUI Chemical Co. Ltd.)

BioVendor Group

LifeSign LLC

Alfa Scientific Designs, Inc.

Eiken Chemical Co., Ltd.

SD Biosensor, INC.

Cenogenics Corporation

TransGen Biotech Co., Ltd.

AdvaCare Pharma

Kibion GmbH

Beijing Huagen Anbang Technology Co., Ltd.

1 INTRODUCTION 30

1.1 OBJECTIVES OF THE STUDY 30
1.2 MARKET DEFINITION 30
1.3 OVERVIEW OF THE ASIA-PACIFIC STOOL DIAGNOSTIC MARKET 30
1.4 LIMITATIONS 32
1.5 MARKETS COVERED 32

2 MARKET SEGMENTATION 35

2.1 MARKETS COVERED 35
2.2 GEOGRAPHICAL SCOPE 36
2.3 YEARS CONSIDERED FOR THE STUDY 36
2.4 CURRENCY AND PRICING 36
2.5 DBMR TRIPOD DATA VALIDATION MODEL 37
2.6 MULTIVARIATE MODELLING 40
2.7 TEST TYPE LIFELINE CURVE 40
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 41
2.9 DBMR MARKET POSITION GRID 42
2.10 MARKET APPLICATION COVERAGE GRID 44
2.11 VENDOR SHARE ANALYSIS 45
2.12 SECONDARY SOURCES 46
2.13 ASSUMPTIONS 46

3 EXECUTIVE SUMMARY 47

4 PREMIUM INSIGHTS 50

4.1 PESTEL ANALYSIS 51
4.2 PORTER'S FIVE FORCES 52

5 INDUSTRY INSIGHTS 53

6 REGULATIONS 54

7 MARKET OVERVIEW 57

7.1 DRIVERS 59
- 7.1.1 INCREASING PREVALENCE OF GASTROINTESTINAL DISEASE 59
- 7.1.2 INCREASING PREVALENCE OF ESOPHAGEAL, COLORECTAL, AND GASTRIC CANCERS 59
- 7.1.3 RISING DEMAND FOR EARLY DISEASE DIAGNOSIS 60
7.2 RESTRAINTS 62
- 7.2.1 STRICT GOVERNMENT REGULATIONS 62
- 7.2.2 HIGH COST ASSOCIATED WITH STOOL DIAGNOSIS 63
7.3 OPPORTUNITIES 64
- 7.3.1 ADVANCEMENTS IN SAMPLE COLLECTION AND HANDLING FOR STOOL DIAGNOSTICS 64
- 7.3.2 RISING DEMAND FOR NON-INVASIVE OR MINIMAL INVASIVE STOOL DIAGNOSTICS 64
7.4 CHALLENGES 65
- 7.4.1 LACK OF SKILLED & CERTIFIED PROFESSIONALS 65
- 7.4.2 LACK OF STANDARDIZATION IN STOOL DIAGNOSTIC PROCEDURE 66

8 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY TEST TYPE 67

8.1 OVERVIEW 68
8.2 PATHOGEN TEST 71
- 8.2.1 H. PYLORI TEST 71
  - 8.2.1.1 H. PYLORI ANTIGEN TEST 72
  - 8.2.1.2 UREA BREATH TEST 72
- 8.2.2 C. DEFFCILE TEST 72
- 8.2.3 OVA & PARASITE TEST 72
- 8.2.4 ROTAVIRUS TEST 72
- 8.2.5 ADENOVIRUS TEST 72
- 8.2.6 SALMONELLA CULTURE TEST 72
- 8.2.7 CAMPYLOBACTER TEST 73
- 8.2.8 EHEC TEST 73
- 8.2.9 OTHERS 73
8.3 FECAL OCCULT BLOOD TEST 73
- 8.3.1 LATERAL FLOW IMMUNO-FOB TEST 74
- 8.3.2 IMMUNO-FOB AGGLUTINATION TEST 74
- 8.3.3 GUAIC FOB STOOL TEST 74
- 8.3.4 OTHERS 74
8.4 FECAL BIOMARKERS TEST 74
- 8.4.1 INFLAMMATORY BIOMARKERS TEST 75
  - 8.4.1.1 FECAL CALPROTECTIN 75
  - 8.4.1.2 FECAL LACTOFERRIN 75
  - 8.4.1.3 OTHERS 75
- 8.4.2 CANCER BIOMARKERS TEST 76
  - 8.4.2.1 COLOGUARD 76
  - 8.4.2.2 M2 PK STOOL TEST 76
  - 8.4.2.3 OTHERS 76
- 8.4.3 OTHERS 76
8.5 MICROSCOPY TEST 77
8.6 STOOL ANTIGEN TEST 77
8.7 FECAL ELASTASE TEST 77
8.8 OTHER TESTS 78

9 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE 79

9.1 OVERVIEW 80
9.2 REAGENTS 83
- 9.2.1 FECAL FLOAT SOLUTIONS 83
- 9.2.2 BUFFER SOLUTIONS 83
- 9.2.3 ABSOLUTE METHANOL 83
- 9.2.4 ACID ALCOHOL 84
- 9.2.5 OTHERS 84
9.3 INSTRUMENTS 84
- 9.3.1 FECALYZERS 85
- 9.3.2 DIGITAL SCALES 85
- 9.3.3 MICROSCOPES 85
- 9.3.4 MICROSCOPE SLIDES 85
- 9.3.5 MICROSCOPE COVER SLIPS 85
- 9.3.6 OTHERS 85

10 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY MODE 86

10.1 OVERVIEW 87
10.2 LABORATORY BASED TESTING 90
10.3 POINT OF CARE TESTING 90

11 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY APPLICATION 91

11.1 OVERVIEW 92
11.2 DIARRHEA 95
11.3 IRRITABLE BOWEL SYNDROME 95
11.4 HEMORRHOIDS 95
11.5 ULCERATIVE COLITIS 96
11.6 CANCER 96
- 11.6.1 COLORECTAL 97
- 11.6.2 COLON 97
- 11.6.3 OTHER 97
11.7 CROHN'S DISEASE 97
11.8 OTHERS 98

12 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY END USER 99

12.1 OVERVIEW 100
12.2 HOSPITALS 103
12.3 DIAGNOSTIC CENTERS 103
12.4 LABORATORIES 103
12.5 SPECIALTY CLINICS 104
12.6 ACADEMIC INSTITUTES AND RESEARCH CENTERS 104
12.7 OTHERS 105

13 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL 106

13.1 OVERVIEW 107
13.2 DIRECT TENDERS 110
13.3 RETAIL SALES 110
13.4 ONLINE SALES 110
13.5 OTHERS 111

14 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET BY REGION 112

14.1 ASIA-PACIFIC 112
- 14.1.1 CHINA 118
- 14.1.2 JAPAN 123
- 14.1.3 INDIA 128
- 14.1.4 SOUTH KOREA 133
- 14.1.5 AUSTRALIA 138
- 14.1.6 MALAYSIA 143
- 14.1.7 INDONESIA 148
- 14.1.8 PHILIPPINES 154
- 14.1.9 THAILAND 159
- 14.1.10 NEW ZEALAND 164
- 14.1.11 TAIWAN 169
- 14.1.12 VIETNAM 174
- 14.1.13 HONG KONG 179
- 14.1.14 SINGAPORE 184
- 14.1.15 PAKISTAN 189
- 14.1.16 BANGLADESH 194
- 14.1.17 SRI LANKA 199
- 14.1.18 CAMBODIA 204
- 14.1.19 NEPAL 209
- 14.1.20 MONGOLIA 214
- 14.1.21 LAOS 219
- 14.1.22 MALDIVES 224
- 14.1.23 BRUNEI 229
- 14.1.24 REST OF ASIA-PACIFIC 234

15 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: COMPANY LANDSCAPE 235

15.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 235

16 SWOT ANALYSIS 236

17 COMPANY PROFILE 237

17.1 EIKEN CHEMICAL CO., LTD. 237
- 17.1.1 COMPANY SNAPSHOT 237
- 17.1.2 REVENUE ANALYSIS 237
- 17.1.3 PRODUCT PORTFOLIO 238
- 17.1.4 RECENT DEVELOPMENT 238
17.2 QUIDEL CORPORATION 239
- 17.2.1 COMPANY SNAPSHOT 239
- 17.2.2 REVENUE ANALYSIS 239
- 17.2.3 PRODUCT PORTFOLIO 240
- 17.2.4 RECENT DEVELOPMENTS 240
17.3 BIOMERIEUX 241
- 17.3.1 COMPANY SNAPSHOT 241
- 17.3.2 REVENUE ANALYSIS 241
- 17.3.3 PRODUCT PORTFOLIO 242
- 17.3.4 RECENT DEVELOPMENTS 242
17.4 SD BIOSENSOR, INC. 243
- 17.4.1 COMPANY SNAPSHOT 243
- 17.4.2 REVENUE ANALYSIS 243
- 17.4.3 PRODUCT PORTFOLIO 244
- 17.4.4 RECENT DEVELOPMENTS 244
17.5 SEKISUI DIAGNOSTICS (A PART OF SEKISUI CHEMICAL CO. LTD.) 245
- 17.5.1 COMPANY SNAPSHOT 245
- 17.5.2 REVENUE ANALYSIS 245
- 17.5.3 PRODUCT PORTFOLIO 246
- 17.5.4 RECENT DEVELOPMENTS 246
17.6 ABBOTT 247
- 17.6.1 COMPANY SNAPSHOT 247
- 17.6.2 REVENUE ANALYSIS 247
- 17.6.3 PRODUCT PORTFOLIO 248
- 17.6.4 RECENT DEVELOPMENT 248
17.7 ADVACARE PHARMA 249
- 17.7.1 COMPANY SNAPSHOT 249
- 17.7.2 PRODUCT PORTFOLIO 249
- 17.7.3 RECENT DEVELOPMENTS 249
17.8 ALFA SCIENTIFIC DESIGNS, INC. 250
- 17.8.1 COMPANY SNAPSHOT 250
- 17.8.2 PRODUCT PORTFOLIO 250
- 17.8.3 RECENT DEVELOPMENTS 250
17.9 BECKMAN COULTER, INC. (SUBSIDIARY OF DANAHER) 251
- 17.9.1 COMPANY SNAPSHOT 251
- 17.9.2 REVENUE ANALYSIS 251
- 17.9.3 PRODUCT PORTFOLIO 252
- 17.9.4 RECENT DEVELOPMENTS 252
17.10 BEIJING HUAGEN ANBANG TECHNOLOGY CO., LTD. 253
- 17.10.1 COMPANY SNAPSHOT 253
- 17.10.2 PRODUCT PORTFOLIO 253
- 17.10.3 RECENT DEVELOPMENT 253
17.11 BIOVENDOR GROUP 254
- 17.11.1 COMPANY SNAPSHOT 254
- 17.11.2 PRODUCT PORTFOLIO 254
- 17.11.3 RECENT DEVELOPMENTS 254
17.12 CENOGENICS CORPORATION 255
- 17.12.1 COMPANY SNAPSHOT 255
- 17.12.2 PRODUCT PORTFOLIO 255
- 17.12.3 RECENT DEVELOPMENTS 255
17.13 DIASORIN S.P.A. 256
- 17.13.1 COMPANY SNAPSHOT 256
- 17.13.2 REVENUE ANALYSIS 256
- 17.13.3 PRODUCT PORTFOLIO 257
- 17.13.4 RECENT DEVELOPMENT 257
17.14 KIBION GMBH (A SUBSIDIARY OF OREXO AB) 258
- 17.14.1 COMPANY SNAPSHOT 258
- 17.14.2 REVENUE ANALYSIS 258
- 17.14.3 PRODUCT PORTFOLIO 259
- 17.14.4 RECENT DEVELOPMENTS 259
17.15 LIFESIGN LLC 260
- 17.15.1 COMPANY SNAPSHOT 260
- 17.15.2 PRODUCT PORTFOLIO 260
- 17.15.3 RECENT DEVELOPMENTS 260
17.16 MERIDIAN BIOSCIENCE INC. 261
- 17.16.1 COMPANY SNAPSHOT 261
- 17.16.2 REVENUE ANALYSIS 261
- 17.16.3 PRODUCT PORTFOLIO 262
- 17.16.4 RECENT DEVELOPMENT 262
17.17 MOLBIO DIAGNOSTICS PVT. LTD. 263
- 17.17.1 COMPANY SNAPSHOT 263
- 17.17.2 PRODUCT PORTFOLIO 263
- 17.17.3 RECENT DEVELOPMENT 263
17.18 PRENETICS LIMITED 264
- 17.18.1 COMPANY SNAPSHOT 264
- 17.18.2 REVENUE ANALYSIS 264
- 17.18.3 PRODUCT PORTFOLIO 265
- 17.18.4 RECENT DEVELOPMENT 265
17.19 RUNMEI 266
- 17.19.1 COMPANY SNAPSHOT 266
- 17.19.2 PRODUCT PORTFOLIO 266
- 17.19.3 RECENT DEVELOPMENTS 266
17.20 TRANSGEN BIOTECH CO., LTD. 267
- 17.20.1 COMPANY SNAPSHOT 267
- 17.20.2 PRODUCT PORTFOLIO 267
- 17.20.3 RECENT DEVELOPMENT 267

18 QUESTIONNAIRE 268

19 RELATED REPORTS 272

LIST OF TABLES

TABLE 1 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 70
TABLE 2 ASIA-PACIFIC PATHOGEN TEST IN STOOL DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 71
TABLE 3 ASIA-PACIFIC H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 72
TABLE 4 ASIA-PACIFIC FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 74
TABLE 5 ASIA-PACIFIC FECAL BIOMARKERS TEST IN STOOL DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 75
TABLE 6 ASIA-PACIFIC INFLAMMATORY BIOMARKERS TEST IN STOOL DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 75
TABLE 7 ASIA-PACIFIC CANCER BIOMARKERS TEST IN STOOL DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 76
TABLE 8 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 82
TABLE 9 ASIA-PACIFIC REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 83
TABLE 10 ASIA-PACIFIC INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 85
TABLE 11 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 89
TABLE 12 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 94
TABLE 13 ASIA-PACIFIC CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 97
TABLE 14 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 102
TABLE 15 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 109
TABLE 16 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 117
TABLE 17 CHINA STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 118
TABLE 18 CHINA PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 118
TABLE 19 CHINA H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 119
TABLE 20 CHINA FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 119
TABLE 21 CHINA FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 119
TABLE 22 CHINA INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 119
TABLE 23 CHINA CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 120
TABLE 24 CHINA STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 120
TABLE 25 CHINA REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 120
TABLE 26 CHINA INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 121
TABLE 27 CHINA STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 121
TABLE 28 CHINA STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 121
TABLE 29 CHINA CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 122
TABLE 30 CHINA STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 122
TABLE 31 CHINA STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 122
TABLE 32 JAPAN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 123
TABLE 33 JAPAN PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 123
TABLE 34 JAPAN H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 124
TABLE 35 JAPAN FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 124
TABLE 36 JAPAN FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 124
TABLE 37 JAPAN INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 124
TABLE 38 JAPAN CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 125
TABLE 39 JAPAN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 125
TABLE 40 JAPAN REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 125
TABLE 41 JAPAN INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 126
TABLE 42 JAPAN STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 126
TABLE 43 JAPAN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 126
TABLE 44 JAPAN CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 127
TABLE 45 JAPAN STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 127
TABLE 46 JAPAN STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 127
TABLE 47 INDIA STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 128
TABLE 48 INDIA PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 128
TABLE 49 INDIA H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 129
TABLE 50 INDIA FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 129
TABLE 51 INDIA FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 129
TABLE 52 INDIA INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 130
TABLE 53 INDIA CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 130
TABLE 54 INDIA STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 130
TABLE 55 INDIA REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 130
TABLE 56 INDIA INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 131
TABLE 57 INDIA STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 131
TABLE 58 INDIA STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 131
TABLE 59 INDIA CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 132
TABLE 60 INDIA STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 132
TABLE 61 INDIA STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 132
TABLE 62 SOUTH KOREA STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 133
TABLE 63 SOUTH KOREA PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 133
TABLE 64 SOUTH KOREA H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 134
TABLE 65 SOUTH KOREA FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 134
TABLE 66 SOUTH KOREA FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 134
TABLE 67 SOUTH KOREA INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 135
TABLE 68 SOUTH KOREA CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 135
TABLE 69 SOUTH KOREA STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 135
TABLE 70 SOUTH KOREA REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 135
TABLE 71 SOUTH KOREA INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 136
TABLE 72 SOUTH KOREA STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 136
TABLE 73 SOUTH KOREA STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 136
TABLE 74 SOUTH KOREA CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 137
TABLE 75 SOUTH KOREA STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 137
TABLE 76 SOUTH KOREA STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 137
TABLE 77 AUSTRALIA STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 138
TABLE 78 AUSTRALIA PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 138
TABLE 79 AUSTRALIA H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 139
TABLE 80 AUSTRALIA FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 139
TABLE 81 AUSTRALIA FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 139
TABLE 82 AUSTRALIA INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 139
TABLE 83 AUSTRALIA CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 140
TABLE 84 AUSTRALIA STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 140
TABLE 85 AUSTRALIA REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 140
TABLE 86 AUSTRALIA INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 141
TABLE 87 AUSTRALIA STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 141
TABLE 88 AUSTRALIA STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 141
TABLE 89 AUSTRALIA CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 142
TABLE 90 AUSTRALIA STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 142
TABLE 91 AUSTRALIA STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 142
TABLE 92 MALAYSIA STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 143
TABLE 93 MALAYSIA PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 143
TABLE 94 MALAYSIA H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 144
TABLE 95 MALAYSIA FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 144
TABLE 96 MALAYSIA FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 144
TABLE 97 MALAYSIA INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 144
TABLE 98 MALAYSIA CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 145
TABLE 99 MALAYSIA STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 145
TABLE 100 MALAYSIA REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 145
TABLE 101 MALAYSIA INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 146
TABLE 102 MALAYSIA STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 146
TABLE 103 MALAYSIA STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 146
TABLE 104 MALAYSIA CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 147
TABLE 105 MALAYSIA STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 147
TABLE 106 MALAYSIA STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 147
TABLE 107 INDONESIA STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 148
TABLE 108 INDONESIA PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 148
TABLE 109 INDONESIA H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 149
TABLE 110 INDONESIA FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 149
TABLE 111 INDONESIA FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 149
TABLE 112 INDONESIA INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 150
TABLE 113 INDONESIA CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 150
TABLE 114 INDONESIA STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 150
TABLE 115 INDONESIA REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 151
TABLE 116 INDONESIA INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 151
TABLE 117 INDONESIA STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 151
TABLE 118 INDONESIA STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 152
TABLE 119 INDONESIA CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 152
TABLE 120 INDONESIA STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 152
TABLE 121 INDONESIA STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 153
TABLE 122 PHILIPPINES STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 154
TABLE 123 PHILIPPINES PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 154
TABLE 124 PHILIPPINES H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 155
TABLE 125 PHILIPPINES FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 155
TABLE 126 PHILIPPINES FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 155
TABLE 127 PHILIPPINES INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 155
TABLE 128 PHILIPPINES CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 156
TABLE 129 PHILIPPINES STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 156
TABLE 130 PHILIPPINES REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 156
TABLE 131 PHILIPPINES INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 157
TABLE 132 PHILIPPINES STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 157
TABLE 133 PHILIPPINES STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 157
TABLE 134 PHILIPPINES CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 158
TABLE 135 PHILIPPINES STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 158
TABLE 136 PHILIPPINES STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 158
TABLE 137 THAILAND STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 159
TABLE 138 THAILAND PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 159
TABLE 139 THAILAND H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 160
TABLE 140 THAILAND FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 160
TABLE 141 THAILAND FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 160
TABLE 142 THAILAND INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 160
TABLE 143 THAILAND CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 161
TABLE 144 THAILAND STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 161
TABLE 145 THAILAND REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 161
TABLE 146 THAILAND INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 162
TABLE 147 THAILAND STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 162
TABLE 148 THAILAND STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 162
TABLE 149 THAILAND CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 163
TABLE 150 THAILAND STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 163
TABLE 151 THAILAND STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 163
TABLE 152 NEW ZEALAND STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 164
TABLE 153 NEW ZEALAND PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 164
TABLE 154 NEW ZEALAND H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 165
TABLE 155 NEW ZEALAND FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 165
TABLE 156 NEW ZEALAND FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 165
TABLE 157 NEW ZEALAND INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 165
TABLE 158 NEW ZEALAND CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 166
TABLE 159 NEW ZEALAND STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 166
TABLE 160 NEW ZEALAND REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 166
TABLE 161 NEW ZEALAND INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 167
TABLE 162 NEW ZEALAND STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 167
TABLE 163 NEW ZEALAND STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 167
TABLE 164 NEW ZEALAND CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 168
TABLE 165 NEW ZEALAND STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 168
TABLE 166 NEW ZEALAND STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 168
TABLE 167 TAIWAN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 169
TABLE 168 TAIWAN PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 169
TABLE 169 TAIWAN H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 170
TABLE 170 TAIWAN FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 170
TABLE 171 TAIWAN FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 170
TABLE 172 TAIWAN INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 170
TABLE 173 TAIWAN CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 171
TABLE 174 TAIWAN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 171
TABLE 175 TAIWAN REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 171
TABLE 176 TAIWAN INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 172
TABLE 177 TAIWAN STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 172
TABLE 178 TAIWAN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 172
TABLE 179 TAIWAN CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 173
TABLE 180 TAIWAN STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 173
TABLE 181 TAIWAN STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 173
TABLE 182 VIETNAM STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 174
TABLE 183 VIETNAM PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 174
TABLE 184 VIETNAM H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 175
TABLE 185 VIETNAM FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 175
TABLE 186 VIETNAM FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 175
TABLE 187 VIETNAM INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 176
TABLE 188 VIETNAM CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 176
TABLE 189 VIETNAM STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 176
TABLE 190 VIETNAM REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 176
TABLE 191 VIETNAM INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 177
TABLE 192 VIETNAM STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 177
TABLE 193 VIETNAM STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 177
TABLE 194 VIETNAM CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 178
TABLE 195 VIETNAM STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 178
TABLE 196 VIETNAM STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 178
TABLE 197 HONG KONG STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 179
TABLE 198 HONG KONG PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 179
TABLE 199 HONG KONG H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 180
TABLE 200 HONG KONG FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 180
TABLE 201 HONG KONG FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 180
TABLE 202 HONG KONG INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 181
TABLE 203 HONG KONG CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 181

TABLE 204 HONG KONG STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 181
TABLE 205 HONG KONG REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 181
TABLE 206 HONG KONG INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 182
TABLE 207 HONG KONG STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 182
TABLE 208 HONG KONG STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 182
TABLE 209 HONG KONG CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 183
TABLE 210 HONG KONG STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 183
TABLE 211 HONG KONG STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 183
TABLE 212 SINGAPORE STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 184
TABLE 213 SINGAPORE PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 184
TABLE 214 SINGAPORE H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 185
TABLE 215 SINGAPORE FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 185
TABLE 216 SINGAPORE FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 185
TABLE 217 SINGAPORE INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 185
TABLE 218 SINGAPORE CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 186
TABLE 219 SINGAPORE STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 186
TABLE 220 SINGAPORE REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 186
TABLE 221 SINGAPORE INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 187
TABLE 222 SINGAPORE STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 187
TABLE 223 SINGAPORE STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 187
TABLE 224 SINGAPORE CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 188
TABLE 225 SINGAPORE STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 188
TABLE 226 SINGAPORE STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 188
TABLE 227 PAKISTAN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 189
TABLE 228 PAKISTAN PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 189
TABLE 229 PAKISTAN H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 190
TABLE 230 PAKISTAN FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 190
TABLE 231 PAKISTAN FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 190
TABLE 232 PAKISTAN INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 190
TABLE 233 PAKISTAN CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 191
TABLE 234 PAKISTAN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 191
TABLE 235 PAKISTAN REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 191
TABLE 236 PAKISTAN INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 192
TABLE 237 PAKISTAN STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 192
TABLE 238 PAKISTAN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 192
TABLE 239 PAKISTAN CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 193
TABLE 240 PAKISTAN STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 193
TABLE 241 PAKISTAN STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 193
TABLE 242 BANGLADESH STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 194
TABLE 243 BANGLADESH PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 194
TABLE 244 BANGLADESH H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 195
TABLE 245 BANGLADESH FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 195
TABLE 246 BANGLADESH FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 195
TABLE 247 BANGLADESH INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 195
TABLE 248 BANGLADESH CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 196
TABLE 249 BANGLADESH STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 196
TABLE 250 BANGLADESH REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 196
TABLE 251 BANGLADESH INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 197
TABLE 252 BANGLADESH STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 197
TABLE 253 BANGLADESH STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 197
TABLE 254 BANGLADESH CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 198
TABLE 255 BANGLADESH STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 198
TABLE 256 BANGLADESH STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 198
TABLE 257 SRI LANKA STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 199
TABLE 258 SRI LANKA PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 199
TABLE 259 SRI LANKA H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 200
TABLE 260 SRI LANKA FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 200
TABLE 261 SRI LANKA FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 200
TABLE 262 SRI LANKA INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 200
TABLE 263 SRI LANKA CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 201
TABLE 264 SRI LANKA STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 201
TABLE 265 SRI LANKA REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 201
TABLE 266 SRI LANKA INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 202
TABLE 267 SRI LANKA STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 202
TABLE 268 SRI LANKA STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 202
TABLE 269 SRI LANKA CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 203
TABLE 270 SRI LANKA STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 203
TABLE 271 SRI LANKA STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 203
TABLE 272 CAMBODIA STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 204
TABLE 273 CAMBODIA PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 204
TABLE 274 CAMBODIA H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 205
TABLE 275 CAMBODIA FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 205
TABLE 276 CAMBODIA FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 205
TABLE 277 CAMBODIA INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 206
TABLE 278 CAMBODIA CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 206
TABLE 279 CAMBODIA STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 206
TABLE 280 CAMBODIA REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 206
TABLE 281 CAMBODIA INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 207
TABLE 282 CAMBODIA STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 207
TABLE 283 CAMBODIA STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 207
TABLE 284 CAMBODIA CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 208
TABLE 285 CAMBODIA STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 208
TABLE 286 CAMBODIA STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 208
TABLE 287 NEPAL STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 209
TABLE 288 NEPAL PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 209
TABLE 289 NEPAL H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 210
TABLE 290 NEPAL FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 210
TABLE 291 NEPAL FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 210
TABLE 292 NEPAL INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 210
TABLE 293 NEPAL CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 211
TABLE 294 NEPAL STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 211
TABLE 295 NEPAL REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 211
TABLE 296 NEPAL INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 212
TABLE 297 NEPAL STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 212
TABLE 298 NEPAL STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 212
TABLE 299 NEPAL CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 213
TABLE 300 NEPAL STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 213
TABLE 301 NEPAL STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 213
TABLE 302 MONGOLIA STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 214
TABLE 303 MONGOLIA PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 214
TABLE 304 MONGOLIA H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 215
TABLE 305 MONGOLIA FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 215
TABLE 306 MONGOLIA FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 215
TABLE 307 MONGOLIA INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 215
TABLE 308 MONGOLIA CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 216
TABLE 309 MONGOLIA STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 216
TABLE 310 MONGOLIA REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 216
TABLE 311 MONGOLIA INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 217
TABLE 312 MONGOLIA STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 217
TABLE 313 MONGOLIA STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 217
TABLE 314 MONGOLIA CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 218
TABLE 315 MONGOLIA STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 218
TABLE 316 MONGOLIA STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 218
TABLE 317 LAOS STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 219
TABLE 318 LAOS PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 219
TABLE 319 LAOS H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 220
TABLE 320 LAOS FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 220
TABLE 321 LAOS FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 220
TABLE 322 LAOS INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 220
TABLE 323 LAOS CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 221
TABLE 324 LAOS STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 221
TABLE 325 LAOS REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 221
TABLE 326 LAOS INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 222
TABLE 327 LAOS STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 222
TABLE 328 LAOS STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 222
TABLE 329 LAOS CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 223
TABLE 330 LAOS STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 223
TABLE 331 LAOS STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 223
TABLE 332 MALDIVES STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 224
TABLE 333 MALDIVES PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 224
TABLE 334 MALDIVES H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 225
TABLE 335 MALDIVES FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 225
TABLE 336 MALDIVES FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 225
TABLE 337 MALDIVES INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 225
TABLE 338 MALDIVES CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 226
TABLE 339 MALDIVES STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 226
TABLE 340 MALDIVES REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 226
TABLE 341 MALDIVES INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 227
TABLE 342 MALDIVES STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 227
TABLE 343 MALDIVES STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 227
TABLE 344 MALDIVES CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 228
TABLE 345 MALDIVES STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 228
TABLE 346 MALDIVES STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 228
TABLE 347 BRUNEI STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 229
TABLE 348 BRUNEI PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 229
TABLE 349 BRUNEI H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 230
TABLE 350 BRUNEI FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 230
TABLE 351 BRUNEI FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 230
TABLE 352 BRUNEI INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 230
TABLE 353 BRUNEI CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 231
TABLE 354 BRUNEI STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 231
TABLE 355 BRUNEI REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 231
TABLE 356 BRUNEI INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 232
TABLE 357 BRUNEI STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 232
TABLE 358 BRUNEI STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 232
TABLE 359 BRUNEI CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 233
TABLE 360 BRUNEI STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 233
TABLE 361 BRUNEI STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 233
TABLE 362 REST OF ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 234

LIST OF FIGURES

FIGURE 1 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: SEGMENTATION 35
FIGURE 2 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: DATA TRIANGULATION 37
FIGURE 3 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: DROC ANALYSIS 38
FIGURE 4 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: ASIA-PACIFIC VS COUNTRY MARKET ANALYSIS 39
FIGURE 5 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: COMPANY RESEARCH ANALYSIS 39
FIGURE 6 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: INTERVIEW DEMOGRAPHICS 41
FIGURE 7 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: DBMR MARKET POSITION GRID 42
FIGURE 8 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: MARKET APPLICATION COVERAGE GRID 44
FIGURE 9 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: VENDOR SHARE ANALYSIS 45
FIGURE 10 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: SEGMENTATION 49
FIGURE 11 INCREASING PREVALENCE OF GASTROINTESTINAL DIASEASE IS EXPECTED TO DRIVE THE ASIA-PACIFIC STOOL DIAGNOSTIC MARKET IN THE FORECAST PERIOD 50
FIGURE 12 PATHOGEN TEST SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC STOOL DIAGNOSTIC MARKET IN 2023 & 2030 50
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA-PACIFIC STOOL DIAGNOSTIC MARKET 58
FIGURE 14 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY TEST TYPE, 2022 68
FIGURE 15 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY TEST TYPE, 2023-2030 (USD THOUSAND) 69
FIGURE 16 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY TEST TYPE, CAGR (2023-2030) 69
FIGURE 17 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY TEST TYPE, LIFELINE CURVE 70
FIGURE 18 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY PRODUCT TYPE, 2022 80
FIGURE 19 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY PRODUCT TYPE, 2023-2030 (USD THOUSAND) 81
FIGURE 20 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY PRODUCT TYPE, CAGR (2023-2030) 81
FIGURE 21 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY PRODUCT TYPE, LIFELINE CURVE 82
FIGURE 22 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY MODE, 2022 87
FIGURE 23 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY MODE, 2023-2030 (USD THOUSAND) 88
FIGURE 24 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY MODE, CAGR (2023-2030) 88
FIGURE 25 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY MODE, LIFELINE CURVE 89
FIGURE 26 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY APPLICATION, 2022 92
FIGURE 27 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY APPLICATION, 2023-2030 (USD THOUSAND) 93
FIGURE 28 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY APPLICATION, CAGR (2023-2030) 93
FIGURE 29 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY APPLICATION, LIFELINE CURVE 94
FIGURE 30 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY END USER, 2022 100
FIGURE 31 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY END USER, 2023-2030 (USD THOUSAND) 101
FIGURE 32 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY END USER, CAGR (2023-2030) 101
FIGURE 33 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY END USER, LIFELINE CURVE 102
FIGURE 34 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY DISTRIBUTION CHANNEL, 2022 107
FIGURE 35 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND) 108
FIGURE 36 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 108
FIGURE 37 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 109
FIGURE 38 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: SNAPSHOT (2022) 113
FIGURE 39 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY COUNTRY (2022) 114
FIGURE 40 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY COUNTRY (2023 & 2030) 114
FIGURE 41 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY COUNTRY (2022 & 2030) 115
FIGURE 42 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: TEST TYPE (2023-2030) 116
FIGURE 43 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: COMPANY SHARE 2022 (%) 235